Evidence map›Paper›PMID 28130345›Full record

ArticleGenes & development2017

The PIDDosome activates p53 in response to supernumerary centrosomes.

Luca L Fava, Fabian Schuler, Valentina Sladky, Manuel D Haschka, Claudia Soratroi, Lisa Eiterer, Egon Demetz, Guenter Weiss, Stephan Geley, Erich A Nigg and 1 more

Abstract read
In one paragraph

Article in Genes & development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Luca L FavaDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Fabian SchulerDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Valentina SladkyDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Manuel D HaschkaDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Claudia SoratroiDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Lisa EitererDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Egon DemetzDepartment of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Guenter WeissDepartment of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Stephan GeleyDivision of Molecular Pathophysiology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Erich A NiggBiozentrum, University of Basel, 4056 Basel, Switzerland.
Andreas VillungerDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centrosomes, the main microtubule-organizing centers in animal cells, are replicated exactly once during the cell division cycle to form the poles of the mitotic spindle. Supernumerary centrosomes can lead to aberrant cell division and have been causally linked to chromosomal instability and cancer. Here, we report that an increase in the number of mature centrosomes, generated by disrupting cytokinesis or forcing centrosome overduplication, triggers the activation of the PIDDosome multiprotein complex, leading to Caspase-2-mediated MDM2 cleavage, p53 stabilization, and p21-dependent cell cycle arrest. This pathway also restrains the extent of developmentally scheduled polyploidization by regulating p53 levels in hepatocytes during liver organogenesis. Taken together, the PIDDosome acts as a first barrier, engaging p53 to halt the proliferation of cells carrying more than one mature centrosome to maintain genome integrity.

Indexed as

A549 CellsAnimalsCaspase 2Cell Cycle CheckpointsCells, CulturedCentrosomeCRADD Signaling Adaptor ProteinCytokinesisDeath Domain Receptor Signaling Adaptor ProteinsGenes, p53HumansLiverMiceMultiprotein ComplexesOrganogenesisTranscriptional ActivationCaspase 2Cradd protein, mouseCRADD Signaling Adaptor ProteinDeath Domain Receptor Signaling Adaptor ProteinsMultiprotein ComplexesPidd1 protein, mousecell divisioncentrosomecytokinesis failurep53

Identifiers

PMID28130345
PMCPMC5287111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.